Thomas A Rasmussen

Summary

Publications

  1. pmc Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial
    Thomas A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
    PLoS ONE 7:e32445. 2012
  2. ncbi request reprint Serum procalcitonin in pulmonary tuberculosis
    T A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
    Int J Tuberc Lung Dis 15:251-6, i. 2011
  3. pmc Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy
    Thomas A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
    BMC Infect Dis 11:267. 2011
  4. pmc Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients
    Anni A Winckelmann
    Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
    PLoS ONE 8:e62074. 2013

Collaborators

Detail Information

Publications4

  1. pmc Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial
    Thomas A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
    PLoS ONE 7:e32445. 2012
    ..Our objective was to compare the bone and renal effects among HIV-infected patients randomized to abacavir or tenofovir-based combination anti-retroviral therapy...
  2. ncbi request reprint Serum procalcitonin in pulmonary tuberculosis
    T A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
    Int J Tuberc Lung Dis 15:251-6, i. 2011
    ..To evaluate the level and prognostic value of procalcitonin (PCT) in a West African out-patient cohort with pulmonary tuberculosis (PTB)...
  3. pmc Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy
    Thomas A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
    BMC Infect Dis 11:267. 2011
    ..Our objective was to evaluate and compare the effect of abacavir on levels of biomarkers associated with cardiovascular risk...
  4. pmc Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients
    Anni A Winckelmann
    Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
    PLoS ONE 8:e62074. 2013
    ..Reductions in proviral load correlated with increasing levels of HIV specific CD8+ T cells. Further investigation into the potential effect of TLR9 agonists on HIV latency is warranted...